|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
IntelGenx Corp. Upgrades to OTCQX(R), the Highest Tier of the OTC Market, on June 14, 2012
6/14/2012 10:10:39 AM
SAINT LAURENT, Quebec, June 14, 2012 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced that its common stock will begin trading on the prestigious OTCQX® U.S. trading platform with effect from June 14, 2012. The OTCQX® is the highest tier of the OTC market and is exclusively for companies that meet the highest financial standards and undergo a qualitative review. IntelGenx' trading symbol, IGXT, will remain the same. In addition, the Company's common shares will continue to trade on the TSX Venture Exchange under the symbol IGX.
|
|
|
|
|
|
|
|
|
|
|